|
Workshop
[In-Person] Demystifying Biopharma Business Development: Understanding the Process and Thriving as a BD Professional
Speakers:
Lesley Stolz (J&J), Jimmy Zhang (previously Merck, J&J, Lilly), Jennifer Leeds (Retired from Novartis), Sarah Bodary (Darwin Bodary Consulting), Matthew Meyer (Life Sciences at Wilson Sonsini Goodrich & Rosati)
Organizers:
Jimmy Zhang (previously Merck, J&J, Lilly), Shichang Miao (PBSS), Dean Wilson (PBSS)
Date:
2025-02-26
Time:
8:45-17:30 Pacific Time
Registration fee:
Regular attendees: $295; Academic/Students/Postdocs/Out-of-Pocket: $45; Major Sponsorship: $3000; Vendor Show: $750, Happy Hour Sponsorship: $1,250; Lunch Sponsorship: $1,500; On-site Registration: $500
Location:
Crowne Plaza, Foster City, CA (San Francisco Bay Area)
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2025-02-25
(it will close sooner if the seating cap is reached)
About the Topic
This full-day workshop will be taught by accomplished business development (BD) professionals with deep experience in both large pharmas and small biotechs, providing perspectives from both sides of the table for biopartnering. If you have ever wondered what BD is, how to work efficiently and effectively with your BD team to advance your company’s strategy and programs, or even how to become a BD professional yourself, this is a good workshop for you (and your colleagues in R&D, regulatory, legal, finance, and even executive positions) to attend. The workshop will include presentations, case studies, and group exercises, and conclude with a panel discussion.
Presentations will cover:
- BD fundamentals
- Search & Evaluation - Due Diligence - Transactions and Negotiation Strategy - Alliance Management
Time (PT) |
Topic |
Speaker |
8:45-9:00 am |
PBSS Welcome |
Shichang Miao, PhD, PBSS |
9:00-10:30 am |
Overview of Business Development |
Jimmy Zhang, PhD, MBA, Biotech BD Executive, previously at Merck, J&J, Lilly Asia Ventures |
10:30-10:40 am |
Major Sponsor Presentation |
Major Sponsor: Ropes & Gray |
10:40-11:00 am |
Break |
- |
11:00-12:00 pm |
Search & Evaluation and Due Diligence in Business Development |
Jennifer Leeds, PhD, Retired from Novartis BD as Head of Search and Evaluation, West Coast and Canada |
12:00-1:00 pm |
Lunch |
Sponsor TBD |
1:00-2:30 pm |
Transactions & Negotiations |
Lesley Stolz, PhD, VP, Early Innovation Partnering, Johnson & Johnson Innovation |
2:30-2:40 pm |
Major Sponsor Presentation |
Major Sponsor TBD |
2:40-3:00 pm |
Break |
- |
3:00-4:00 pm |
Alliance Management and Summary |
Sarah Bodary, PhD, Biotech Advisor/Investor, Darwin Bodary Consulting |
4:00-4:30 pm |
Best Practices and Avoiding Pitfalls in Biotech Dealmaking |
Matthew Meyer, JD, Chief Business Advisor, Life Sciences at Wilson Sonsini Goodrich & Rosati |
4:30-5:00 pm |
Panel Discussion |
All Speakers |
5:00-6:00 pm |
Happy Hour |
Sponsor TBD |
2025-03-07, [In-Person] Clinical Trial Planning and Conduct: Fundamentals, Strategies and Best Practices
|
2025-03-27, [Free Online Workshop] Biotech Financing 101: from Angels, Government Agencies, Foundations and VCs
|
2025-04-01, [For vendors ONLY] Seattle PBSS Seminar Luncheon Vendor Show
|
2025-04-09, [In-Person] Cell Therapy Discovery and Development: Fundamentals, Strategies and Best Practices (jointly by PBSS and RAPS-SF)
|
2025-04-22, [Free Online Workshop] Career Transitions for Research Scientists: BD/Sales in CROs, CDMOs, and Lab Products & Instruments
|
2025-04-25, [In-Person] Drug Metabolism Fundamentals and Metabolite Identification
|
2025-05-05, [Free Online] Highlights of 2024 FDA Drug Approvals
|
2025-05-12, [In-Person] Preclinical Pharmacology Studies and Translational Medicine for Drug Discovery and Development
|
2025-06-02, [In-Person] Metabolism and Transport-mediated Drug-Drug Interaction: Current Practices, Regulatory Guidances, and Their Impact on Drug Development
|
|
Ads (in random order)
Submit a Text Ad ($250 for 2 months)
Alturas Analytics, Inc.
Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
|
Hypha Discovery
Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
|
Allucent
Experts bringing development innovation w/ClinPharm Modeling & Simulation deliverables to inform dose, study design, modeling+development strategies.
|
Submit a Text Ad
|